AGNP BOARD EXAM QUESTION AND ANSWERS – NEUROLOGY ASSESSMENT
(102 Questions)
Question:
Which of the following medications is NOT a serotonin 5-HT1
... [Show More] receptor agonist?
Axert.
Fioricet. Correct
Maxalt.
Zomig.
Explanation:
Fioricet is a combination of butalbital, acetaminophen and caffeine. Axert (almotriptan), Maxalt (rizatriptan), Zomig (zolmitriptan) are all classified as serotonin 5-HT1 receptor agonists, or triptans.
Question:
A patient presenting with a transient ischemic attack (TIA) is taking nifedipine (Adalat CC) for hypertension. Pharmacokinetics of nifedipine may be altered in patients with:
renal insufficiency.
hepatic impairment. Correct
irritable bowel disease.
G6PD deficiency.
Explanation:
Since hepatic biotransformation is the predominant route for the disposition of nifedipine, the pharmacokinetics may be altered in patients with chronic liver disease. Patients with hepatic impairment have a longer disposition half-life and higher bioavailability of nifedipine than healthy volunteers.
Question:
Oxcarbazepine (Trileptal) is structurally similar to:
carbamazepine (Tegretol). Correct
divalproex sodium (Depakote).
lamotrigine (Lamictal).
topiramate (Topamax).
Explanation:
As the name suggests, oxcarbazepine (Trileptal) is related to carbamazepine (Tegretol, Carbatrol) and appears to be similarly effective for controlling complex partial seizures and primary and secondary generalized tonic-clonic seizures. It seems to cause fewer unwanted side effects in many (but not all) patients. Oxcarbazepine is not effective against absence or myoclonic seizures.
Question:
Patients who experience greater than 7 to 9 tension-type headaches per month may be considered for maintenance therapy including:
anticonvulsants and tricyclic antidepressants.
antidepressants and beta-blockers.
anticonvulsants and muscle relaxants.
muscle relaxants and tricyclic antidepressants. Correct
Explanation:
Patients who experience greater than 7 to 9 tension-type headaches per month may be considered for maintenance therapy including muscle relaxants (i.e., tizanidine) and tricyclic antidepressants (i.e., amitriptyline). Muscle relaxants are considered second-line therapy to be added to TCAs if inadequate in reducing headache episodes. Antiepileptics and beta-blockers may be indicated for the prophylactic treatment of migraines. There is more evidence of effectiveness with amitriptyline than doxepin, or with other antidepressants such as venlafaxine and mirtazapine. Doses used are generally low and not in the range used to treat depression. The need for continued chronic treatment of tension-type headaches should be reviewed at least every 6 months.
Question:
Beta-blockers, used for the prophylactic treatment of migraines, would NOT be contraindicated in a patient with a history of:
ventricular arrhythmias.
2nd degree heart block.
pulmonary congestion.
acute coronary syndrome. Correct
Explanation:
Beta-blockers are contraindicated in patients who have a history of ventricular arrhythmias, sick sinus syndrome, 2nd or 3rd degree heart block, cardiogenic shock, and pulmonary congestion. Beta-blockers are indicated in acute coronary syndrome in order to prevent recurrent ischemia and life-threatening ventricular arrhythmias.
Question:
Patients who are taking carbidopa/levodopa (Sinemet) for Parkinson's disease should be advised to avoid a diet high in:
carbohydrates.
fat.
protein. Correct
sodium.
Explanation: [Show Less]